Search Results

Intelligent Dialysis Assistant (IDA) is intended for automatic single exchange of dialysate solution exchanges in the treatment of adult renal failure patients undergoing peritoneal dialysis.

All therapies using the Intelligent Dialysis Assistant (IDA) must be prescribed and performed under the responsibility of a physician who is familiar and well informed about peritoneal dialysis. The patient prescription may include single or multiple exchanges, depending on the patient's need.

The IDA Cartridge is a single-use, sterile cartridge exclusively for use with the IDA. It is intended to interface the IDA with the Twin Bag Set (patient dialysis prescription) and the patient's peritoneal catheter.

The Medical Supervision Portal is intended for use by healthcare professionals to remotely communicate new or modified treatment parameters with compatible dialysis instruments and transfer completed treatment database to aid in the review, analysis, and evaluation of patients' historical treatment results. This Medical Supervision Portal is not intended to be a substitute for good clinical management practices, nor does its operation creatment pathways.

The IDA Smartphone App is a software medical application intended for patients to review their treatment and review and approve their dialysis prescription provided by the healthcare professional through the Medical Supervision Portal. The user is not intended to take clinical action based on the application of a qualified healthcare professional.

Not Found

The provided FDA 510(k) clearance letter for the "Digital Dialysis Clinic - Intelligent Dialysis Assistant (IDA) & IDA Cartridge with Medical Supervision Portal and IDA Smartphone App" primarily focuses on the substantial equivalence determination for regulatory clearance. It does not contain specific details about the acceptance criteria or a detailed study proving the device meets those criteria, as typically found in clinical study reports or more comprehensive device descriptions.

The letter confirms the device's classification, intended use, and substantial equivalence to predicate devices, but lacks the in-depth technical and clinical performance data required to answer your specific questions about acceptance criteria, detailed study methodology, ground truth establishment, or human-AI interaction effects.

Therefore, I cannot provide the requested information from the given text. To answer your questions, you would typically need to consult a detailed clinical study report, a regulatory submission, or technical documentation for the device, which are not included in this FDA clearance letter.

Ask a specific question about this device